Notice of Effectiveness (effect)
July 19 2017 - 6:01AM
Edgar (US Regulatory)
UNITED STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
Effective Date:
|
July 18,
2017
|
Accession Number:
|
0001193125-17-226254
|
Submission Type:
|
POS AM
|
CIK:
|
0001390478
|
Company Name:
|
Galena Biopharma, Inc.
|
File Number:
|
333-213908
|
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2023 to Apr 2024